52

Bharat Immunologicals and Biologicals Corporation LtdBOM 524663

Последний отчетный период 31 мар., 2023

Обновлено 19 сент., 2024

Последняя цена

Капитализация млрд. $

0.01

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 524663.BO

52

Нет оценки

Количественный анализ Eyestock не покрывает акции Bharat Immunologicals and Biologicals Corporation Ltd.

Капитализация млрд. $

0.01

Дивидендная доходность

Оборот

43.18 млрд

Сайт компании

https://www.bibcol.com/

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. The company operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

Смотреть Секцию: Рейтинг